IVD Enterprises Achieved Cooperation In the 3rd CIIE

A number of IVD enterprises, such as KingMed and Danaher, Roche and GE,Wondfo and AstraZeneca,DIAN and Roche achieved cooperation in the 3rd CIIE

KingMed Diagnostics and Danaher Diagnostics platform signed a strategic cooperation agreement.

On November 5, 2020, KingMed Diagnostics and Danaher Diagnostics reached a strategic cooperation intention. The two sides will work together to promote real world data research and follow-up applications of new technologies of Danaher  Beckman ’s MDW, COVID antibodies and Cepheid's innovative Pathogen Diagnosis module to strengthen the cooperation between KingMed Diagnostics and Danaher in the research, transformation and clinical application of new technologies to serve the health of China.

The cooperation between KingMed Diagnostics and Danaher Diagnostics is a strong combination of two leaders in the field of pathogen diagnosis, which will better promote the innovation and development of pathogen diagnosis technology, improve the diagnostic level of infectious diseases in China, and contribute to the construction of China's public health system.

Roche Diagnostics and GE  signed a memorandum of strategic cooperation at the CIIE.

On November 6, 2020, Roche Diagnostics China and GE China signed a memorandum of strategic cooperation at the 3rd China International Import Expo.

The two sides announced that they will carry out in-depth cooperation on innovation model building at the channel level, application and implementation of solutions in key disease diagnosis fields, and research and development of forward-looking technologies. The purpose of this cooperation is to deepen the partnership for market development in China, accelerate the implementation of more innovative in vitro and in vivo diagnostic technologies and treatment programs in China, and jointly promote the establishment of an innovative disease management ecosystem based on accurate diagnosis for the benefit of Chinese patients.

Wondfo Biotech and AstraZeneca signed a contract for international cooperation on the Belt and Road Initiative.

On November 6, 2020, Wondfo Biotech and AstraZeneca signed the Belt and Road international cooperation agreement at the China International Import Expo.The two parties will strengthen the promotion of international cooperation in early screening and diagnosis of prostate cancer, and explore the international development path of prostate cancer management in some countries and regions in Asia, Central America and Latin America, the Middle East and Africa.Currently, the two sides plan to complete 15,000 screenings in Latin America by the end of this year, and to complete more than 300,000 cases in cooperative countries around the world in 2021.

DIAN Diagnostics and Roche Diagnostics signed a contract at the 3rd CIIE.

On November 6, 2020, at the 3rd China International Import Expo—Zhejiang International Medical Supplies Intentional Purchasing Signing Conference, DIAN Diagnostics and Roche Diagnostics (Shanghai) Co., Ltd. signed the "Letter of Intent for the Purchasing of Imported Medical Devices." This is the third consecutive year that DIAN Diagnostics has reached relevant procurement intentions with Roche Diagnostics at the CIIE, showing a long-term and good cooperation trend.

DIAN Diagnostics CEO Baixing Huang and Roche Diagnostics Vice President  Xianglin Chen signed the contract on behalf of both parties. Changcong  Su, First Inspector of Zhejiang Provincial Health Commission,  Yuanchang Gong, Deputy Director and First Inspector of Zhejiang Medical Security Bureau, Shuming Zhang, Deputy Director of Zhejiang Provincial Department of Commerce,  Wenbin Miao, Party Leadership Member and Chief Engineer of Zhejiang Provincial Department of Economy and Information Technology, etc. Leaders witnessed on site.

Zhejiang International Medical Supplies Intentional Purchasing Signing Conference was jointly organized by Zhejiang Provincial Health Commission, Zhejiang Medical Security Bureau, Zhejiang Provincial Department of Commerce, and Zhejiang Provincial Department of Economics and Information Technology. The on-site focus was on imported drugs, imported medical consumables, and imported large-scale Intentional contract for medical equipment, etc.The total intended purchase amount is 10.708.5 billion YUAN, a slight increase over last year, ranking among the top of all trading groups in the province.